SAN DIEGO--(BUSINESS WIRE)--Biocom, the association representing the California life science industry, today announced the appointment of four new members to its board. In addition, Biocom also announced that board members David Enloe, president and chief executive officer of Althea, and Wolfgang Glaesner, Ph.D., CSO-AME of Eli Lilly, are now on the Executive Committee.
“Our board of directors is essential to our mission and a vital resource for Biocom as our association expands across the state,” said Joe Panetta, president and CEO of Biocom. “These four new members bring fresh insights, diverse backgrounds, and unique skills to Biocom. With the largest board of any life science association in the state, Biocom is uniquely prepared to accelerate the growth of the life science clusters in San Diego, Orange County, the greater Los Angeles area, and the San Francisco Bay Area.”
Biocom’s board member appointments include Rick Bregman, San Diego market president and national co-head of Bank of America’s Healthcare Banking Group, Jennifer Giottonini Cayer, president and chief executive officer of 3E Therapeutics, Nazeli Dertsakian, vice president and general manager of product operations at Genentech Oceanside and Cheston Larson, partner of Latham & Watkins, San Diego.
“With more than 1,000 members, our organization’s expansion requires expertise from a wide range of industries, as highlighted by our new appointments. Our new members bring valuable skills in finance, research, production operations, business development and law,” concluded Panetta.
Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 1,000 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.
Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to its San Diego headquarters, Biocom operates a core office serving the Los Angeles market, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in the San Francisco Bay area and Sacramento. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.